The red blood cell as a biosensor for monitoring oxidative imbalance in chronic obstructive pulmonary disease: An ex vivo and in vitro study

Antioxidants and Redox Signaling

Volumn 8, Issue 7-8, 2006, Pages 1171-1182

  Lucantoni, Gabriele ^a   Pietraforte, Donatella ^b   Matarrese, Paola ^b   Gambardella, Lucrezia ^b   Metere, Alessio ^b   Paone, Gregorino ^a   Li Bianchi, Enrico ^a   Straface, Elisabetta ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

AGED; ARTICLE; BIOSENSOR; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG EFFICACY; ERYTHROCYTE; EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; ITALY; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACETYLCYSTEINE; AGED; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; BIOSENSING TECHNIQUES; CASE-CONTROL STUDIES; CELL SHAPE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FEMALE; GLYCOPHORIN; HUMANS; MALE; METHEMOGLOBIN; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXYNITROUS ACID; PROTEIN-TYROSINE-PHOSPHATASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 33746810931     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.1171     Document Type: Article

References (39)

1. American Thoracic Society. ATS Statement, Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 166: 111-117, 2002.
2. Andrews DA and Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 6: 76-82, 1999.
3. Augusto O, Lopes de Menezes S, Linares E, Romero N, Radi R, and Denicola A. EPR detection of glutathiyl and hemoglobin-cysteinyl radicals during the interaction of peroxynitrite with human erythrocytes. Biochemistry 41: 14323-14328, 2002.
4. Baker PRS, Schopfer FJ, Sweeney S, and Freeman BA. Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc Natl Acad Sci U S A 101: 11577-11582, 2004.
5. Barnes PJ, Shapiro SD, and Pauwels RA. Chronic obstructive pulmonary disease: Molecular and cellular mechanisms. Eur Respir J 22: 672-688, 2003.
6. Barreiro E, Gea J, Corominas JM, and Hussain SN. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 29: 771-778, 2003.
7. Berliner S, Rogowski O, Aharonov S, Mardi T, Tolshinsky T, Rozenblat M, Justo D, Deutsch V, Serov J, Shapira I, and Zeltzer D. Erythrocyte adhesiveness/aggregation: A novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J 149: 260-267, 2005.
8. Caprari P, Bozzi A, Malorni W, Bottini A, Iosi F, Santini MT, and Salvati AM. Junctional sites of erythrocyte skeletal proteins are specific targets of tert-butylhydroperoxide oxidative damage. Chem Biol Interact 94: 243-258, 1995.
9. Decramer M, De Benedetto F, Del Ponte A, and Marinari S. Systemic effects of COPD. Respir Med 99(suppl 2): S3-S10, 2005.
10. Dekhuijzen PN. Antioxidant properties of N-acetylcysteine: Their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J 23: 629-636, 2004.
11. Denicola A, Souza, JM, and Radi R. Diffusion of peroxynitrite across erythrocyte membranes. Proc Natl Acad Sci U S A 95: 3566-3571, 1998.
12. Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Augusti A, and MacNee W. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 60: 293-300, 2005.
13. Foschino Barbaro MP, Serviddio G, Resta O, Rollo T, Tamborra R, Elisiana Carpagnano G, Vendemiale G, and Altomare E. Oxygen therapy at low flow causes oxidative stress in chronic obstructive pulmonary disease: Prevention by N-acetyl cysteine. Free Radic Res 39: 1111-1118, 2005.
14. Gerrits CM, Herings RM, Leufkens HG, and Lammers JW. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease. Eur Respir J 21: 795-798, 2003.
15. Hiemstra PS, Van Wetering S, and Stolk J. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: Effects on pulmonary epithelium. Eur Respir J 12: 1200-1208, 1998.
16. John M, Lange A, Hoernig S, Witt C, and Anker SD. Prevalence of anemia in chronic obstructive pulmonary disease: Comparison to other chronic diseases. Int J Cardiol 2005 (in press).
17. Kharitonov SA. Influence of different therapeutic strategies on exhaled NO and lung inflammation in asthma and COPD. Vascul Pharmacol 2005 (in press).
18. Liu X, Qin W, and Yin D. Biochemical relevance between oxidative/carbonyl stress and elevated viscosity of erythrocyte suspensions. Clin Hemorheol Microcirc 31: 149-156, 2004.
19. Lopez AD and Murray CC. The global burden of disease, 1990-2020. Nat Med 4: 1241-1243, 1998.
20. MacNee W. Oxidants/antioxidants and COPD. Chest 117: 303S-317S, 2000.
21. Mallozzi C, Di Stasi AM, and Minetti M. Peroxynitrite modulates tyrosine-dependent signal transduction pathway of human erythrocyte band 3. FASEB J 11: 1281-1290, 1997.
22. 31P-MRS. J Appl Physiol 78: 2218-2227, 1995.
23. Matarrese P, Straface E, Pietraforte D, Gambardella L, Vona R, Maccaglia A, Minetti M, and Malorni W. Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases. FASEB J 19: 416-418, 2005.
24. McMahon TJ, Ahearn GS, Moya MP, Gow AJ, Huang YC, Luchsinger BP, Nudelman R, Yan Y, Krichman AD, Bashore TM, Califf RM, Singel DJ, Piantadosi CA, Tapson VF, and Stamler JS. A nitric oxide processing defect of red blood cells created by hypoxia: Deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc Natl Acad Sci U S A 102: 14801-14806, 2005.
25. Mohandas N. Molecular basis for red cell membrane viscoelastic properties. Biochem Soc Trans 20: 776-782, 1992.
26. Poole PJ and Black PN. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: Systematic review. BMJ 322: 1271-1274, 2001.
27. Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, and Freeman BA. Detection of catalase in rat heart mitochondria. J Biol Chem 266: 22028-22034, 1991.
28. Rahman I, Li XY, Donaldson K, Harrison DJ, and MacNee W. Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol 269: 285-292, 1995.
29. Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys 43: 167-188, 2005.
30. Rauwels RM, Buist AS, Calverley PM, Jenkins CR, and Hurd SS for the GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 163: 1256-1276, 2001.
31. Rogowski O, Berliner S, Zeltser D, Serov J, Ben-Assayag E, Justo D, Rozenblat M, Kessler A, Deutsch V, Zakuth V, and Shapira I. The erythrosense as a real-time biomarker to reveal the presence of enhanced red blood cell aggregability in atherothrombosis. Am J Ther 12: 286-292, 2005.
32. Romero N, Denicola A, Souza JM, and Radi R. Diffusion of peroxynitrite in the presence of carbon dioxide. Arch Biochem Biophys 368: 23-30, 1999.
33. Santos MC, Oliveira AL, Viegas-Crespo AM, Vincente L, Barreiros A, Monteiro P, Pinheiro T, and Bungalho De Almeida A. Systemic markers of the redox balance in chronic obstructive pulmonary disease. Biomarkers 9: 461-469, 2004.
34. Straface E, Matarrese P, Gambardella L, Forte S, Carlone S, Libianchi E, Schmid G, and Malorni W. N-Acetylcysteine counteracts erythrocytes alterations occurring in chronic obstructive pulmonary disease. Biochem Biophys Res Commun 279: 552-556, 2000.
35. Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc 21: 71-77, 2005.
36. 2-agonists in asthma. Eur Respir J 19: 240-245, 2002.
37. Winterbourn CC. Oxidative reactions of hemoglobin. Methods Enzymol 186: 265-267, 1990.
38. Wouters EF. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2: 26-33, 2005.
39. Zipser Y and Kosower NS. Phosphotyrosine phosphatase associated with band 3 protein in the human erythrocyte membrane. Biochem J 314: 881-887, 1996.